PHARMACOKINETICS OF BEZAFIBRATE AFTER SINGLE AND MULTIPLE DOSES IN THE PRESENCE OF RENAL-FAILURE

被引：30

作者：

ABSHAGEN, U ^{[1
]}

KOSTERS, W ^{[1
]}

KAUFMANN, B ^{[1
]}

LANG, PD ^{[1
]}

机构：

[1] STADT KRANKENANSTALTEN MANNHEIM,NEPHROL ABT,MANNHEIM,FED REP GER

来源：

KLINISCHE WOCHENSCHRIFT | 1980年 / 58卷 / 17期

关键词：

D O I：

10.1007/BF01477001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：889 / 896

页数：8

相关论文

共 15 条

[1] DISPOSITION PHARMACOKINETICS OF BEZAFIBRATE IN MAN
ABSHAGEN, U
BABLOK, W
KOCH, K
LANG, PD
SCHMIDT, HAE
SENN, M
STORK, H
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (01) : 31 - 38
[2] STEADY-STATE KINETICS OF BEZAFIBRATE AND CLOFIBRATE IN HEALTHY FEMALE VOLUNTEERS
ABSHAGEN, U
SPORLRADUN, S
MARINOW, J
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (04) : 305 - 308
[3] ADAM O, 1979, MUNCHEN MED WOCHEN, V121, P319
[4] ARNTZ HR, 1978, MED KLIN, V73, P1731
[5] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF BEZAFIBRATE IN SERUM AND URINE
ENDELE, R
[J]. JOURNAL OF CHROMATOGRAPHY, 1978, 154 (02): : 261 - 263
[6] CLOFIBRATE DISPOSITION IN RENAL-FAILURE AND ACUTE AND CHRONIC LIVER-DISEASE
GUGLER, R
KURTEN, JW
JENSEN, CJ
KLEHR, U
HARTLAPP, J
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (05) : 341 - 347
[7] KAFFARNIK H, 1978, INT C ATHEROSCLEROSI, P129
[8] LAGEDER H, 1978, INT C ATHEROSCLEROSI, P726
[9] EFFECT OF BM 15.075 ON LIPOPROTEIN CONCENTRATIONS IN DIFFERENT TYPES OF HYPERLIPOPROTEINEMIA
OLSSON, AG
ROSSNER, S
WALLDIUS, G
CARLSON, LA
LANG, PD
[J]. ATHEROSCLEROSIS, 1977, 27 (03) : 279 - 287
[10] ONE-YEAR STUDY OF EFFECT OF BEZAFIBRATE ON SERUM LIPOPROTEIN CONCENTRATIONS IN HYPERLIPOPROTEINEMIA
OLSSON, AG
LANG, PD
[J]. ATHEROSCLEROSIS, 1978, 31 (04) : 429 - 433